Stocks · Health care · Biological Products, (No Diagnostic Substances)

4D Molecular Therapeutics, Inc.

FDMT Clue Score62
United States Fiscal year ends December CIK 0001650648 Results filed 13 Aug 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Charles Theuer
12 Dec 2025
Director
Exercised, kept
9,333
$1.14
$10.64K

What was left out

Form 4 filings counted 31
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 15
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 88,275
History held since 17 Dec 2020